ScholarIQanswers from OpenAlex

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

PaperCitations, authors & open-access status

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist have?

ScholarIQcitation count

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist has 672 citations in the OpenAlex counts ScholarIQ stores.

When was Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist published?

ScholarIQyear

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist has 2003 year in the ScholarIQ index.

What is the open-access status of Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

ScholarIQoa status

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist has closed oa status in the ScholarIQ index.

What is the DOI of Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

ScholarIQdoi

The DOI for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is on the source record.

What is the PMID of Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

ScholarIQpmid

The PMID for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is on the source record.

What is the OpenAlex record for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

ScholarIQopenalex

The OpenAlex for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial